Aug 3 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2018 Jun 30, 2017 Dec 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 90 mln 19 mln 230 mln
(+354.4 pct) (-55.5 pct) (+0.4 pct)
Operating loss 643 mln loss 509 mln loss 1.40
Recurring loss 639 mln loss 517 mln loss 1.40
Net loss 641 mln loss 518 mln loss 1.40
EPS loss 57.89 yen loss 53.89 yen loss 126.29 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T